Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.
about
Update in lung cancer 2007Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesAssessment, origin, and implementation of breath volatile cancer markers.Serum amyloid A: an acute-phase protein involved in tumour pathogenesisUpdates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemopreventionUnlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancerA novel comprehensive wave-form MS data processing method.A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screeningAdvances in proteomic strategies toward the early detection of lung cancerInformed baseline subtraction of proteomic mass spectrometry data aided by a novel sliding window algorithm.Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen.Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients.Diagnostic characteristics of a serum biomarker in patients with positron emission tomography scans.A blood-based proteomic classifier for the molecular characterization of pulmonary nodules.Comparison of plasma from healthy nonsmokers, smokers, and lung cancer patients: pattern-based differentiation profiling of low molecular weight proteins and peptides by magnetic bead technology with MALDI-TOF MS.Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned mediumSeven-signal proteomic signature for detection of operable pancreatic ductal adenocarcinoma and their discrimination from autoimmune pancreatitis.MALDI-MS-Based Profiling of Serum Proteome: Detection of Changes Related to Progression of Cancer and Response to Anticancer Treatment.High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications.Serum biomarkers identification by mass spectrometry in high-mortality tumors.Quality assessment for clinical proteomics.Added value of a serum proteomic signature in the diagnostic evaluation of lung nodulesTransfer learning of classification rules for biomarker discovery and verification from molecular profiling studiesThe state of molecular biomarkers for the early detection of lung cancer.Mass spectrometry-based proteomic profiling of lung cancer.Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection.Better cancer biomarker discovery through better study design.Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients.Respiratory Proteomics Today: Are Technological Advances for the Identification of Biomarker Signatures Catching up with Their Promise? A Critical Review of the Literature in the Decade 2004-2013.Early detection and screening of lung cancer.Assessment of individual lung cancer risk by the proteomic analysis of exhaled breath condensate.Proteomic biomarkers in lung cancer.Molecular biomarkers for future screening of lung cancer.Evaluation and management of pulmonary nodules: state-of-the-art and future perspectives.The clonal evolution and therapeutic approaches of lung cancer.Current status of circulating protein biomarkers to aid the early detection of lung cancer.Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers.Comparative proteomic analysis of non-small-cell lung cancer and normal controls using serum label-free quantitative shotgun technology.
P2860
Q22241904-353A6FDB-551E-4892-9503-776663E4C0A8Q27023830-1C9E5652-FF70-4235-95F3-BC8C3F6749A9Q27692565-C03099F7-7188-47C3-9CA9-C34E230C8446Q28291806-0A9F0FC4-4C76-4465-9D09-FC66B32D52D8Q28388931-9850C442-2C97-455F-BD48-70F88D30E6FDQ28744369-95037C9A-0B0B-4E81-8A9D-717DCF6E6FE1Q30489778-29B5173F-5DE1-4E42-A6FF-DA0428389DA2Q30511822-46E1FF78-25DE-4754-A918-F68A6EED5B8CQ31008766-255E6EBE-C2C0-41C6-8DA5-41F8CE63D1E5Q31149213-724F54E9-7982-4001-874B-6FB0F5F0DE99Q33436643-67B61FF4-8112-461E-B759-011233A4D58BQ33525226-E4106959-4B40-401A-A230-0027F5AE4BB7Q33584655-B8D8B905-53CA-46E6-9A88-5DE18F235397Q33968948-F742610E-00E5-4D35-ACB0-122ED6BF81E7Q34166788-0C76AC2C-2852-4A96-855F-7AF28C817103Q34350615-9A836C69-EAF8-4A4D-857D-5C9B616D3E57Q35104929-8B14ADE6-8D73-455D-A50D-FDB3F04ADEEFQ35957217-339761C7-0124-4217-B9DD-E12F8E5AD920Q35990884-D0CA15F6-7654-447E-BA75-15B61D1537BDQ36147848-A1B5B784-7192-4ADB-921A-E7492D7AE013Q36288148-C0ED1592-2BC2-446C-8670-BE84AF036569Q36582422-580B80EB-0A03-4B89-AFCA-AC79DD9F8031Q36698467-BC36489D-8563-46FD-A8D0-E3DF68DDAB76Q36862617-D3319596-82DF-44C4-9DBD-7A510C8C5DF8Q36996151-19B2EC61-BC37-4B7F-8361-7571DA17FE76Q37044593-68DFFDDA-E7A0-497A-A9EF-4675B89D2B5CQ37171914-CFE15502-430D-46AA-A253-8D1D6ADA49FDQ37231517-12B15D46-B59D-4D19-9BEF-12AA5EE553DAQ37310041-EDFD90AF-9E27-460A-9C00-46BB8A326154Q37382420-40486452-C62F-4878-8073-DED7025312A8Q37636429-8F9729FA-3AAE-4B9B-BE4D-96F9DD4A1167Q37789035-7C9613F3-23AC-4A94-BB8C-EB8E761B452CQ38089947-C03AA894-5103-4A3B-93B9-32CAC506C583Q38100750-6CDBEECF-7FDB-4EF9-A3B7-9B60E076B9C3Q38124776-23CDC298-2703-4398-AB74-B4827B3642C5Q38157016-4877F5D8-904F-44F1-BCC5-B599BC481F61Q38196755-430B0C3D-F037-4AC5-A019-D3FBD85C2980Q38232856-9188D954-2DCF-4F7E-B7DD-6B1EC6680292Q38238438-248B2279-64DA-4958-B0E4-C3C7BF2DDFE9Q42654558-46F70D61-7DD3-4E62-B476-5FBACAB66AC1
P2860
Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Diagnostic accuracy of MALDI m ...... tionated serum in lung cancer.
@ast
Diagnostic accuracy of MALDI m ...... tionated serum in lung cancer.
@en
Diagnostic accuracy of MALDI m ...... tionated serum in lung cancer.
@nl
type
label
Diagnostic accuracy of MALDI m ...... tionated serum in lung cancer.
@ast
Diagnostic accuracy of MALDI m ...... tionated serum in lung cancer.
@en
Diagnostic accuracy of MALDI m ...... tionated serum in lung cancer.
@nl
prefLabel
Diagnostic accuracy of MALDI m ...... tionated serum in lung cancer.
@ast
Diagnostic accuracy of MALDI m ...... tionated serum in lung cancer.
@en
Diagnostic accuracy of MALDI m ...... tionated serum in lung cancer.
@nl
P2093
P2860
P1476
Diagnostic accuracy of MALDI m ...... ctionated serum in lung cancer
@en
P2093
Adriana L Gonzalez
Bashar Shakhtour
David H Johnson
David P Carbone
Heinrich Roder
Jamshedur S M Rahman
Jill M Siegfried
Joel L Weissfeld
Lisa J Zimmerman
Mathew Ninan
P2860
P304
P356
10.1097/JTO.0B013E31814B8BE7
P577
2007-10-01T00:00:00Z